Form D · Biotechnology
Ribon Therapeutics, Inc.
Cambridge, MA · CIK 0001660410
Offering snapshot reported Dec 22, 2022 · SEC filing
- Reported sold
- $25M Offering amount: $25M
- Investors reported
- 1 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Dec 22, 2022 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Dec 22, 2022 | Initial | $25,000,000 | No comparison | 1 | SEC filing |
| Jun 14, 2021 | Initial | $25,150,140 | No comparison | Not reported | SEC filing |
| Jan 4, 2019 | Initial | $25,415,384 | No comparison | 10 | SEC filing |
| Oct 10, 2017 | Initial | $20,000,001 | No comparison | 8 | SEC filing |
| Nov 23, 2016 | Amendment | $23,500,000 | $13,500,000vs Dec 17, 2015 | 5 | SEC filing |
| Dec 17, 2015 | Initial | $10,000,000 | No comparison | 3 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-468515
Source: Form D, filed Dec 22, 2022. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| James Audia | Director |
| Paul Brannelly | Executive |
| Laura Brass | Director |
| David Cordo | Executive |
| Jeff Goater | Director |
| William Harrington | Director |
| Anja Koenig | Director |
| Laurence Lasky | Director |
| Eyal Lifschitz | Director |
| Jodie Morrison | Director |
| Marian Nakada | Director |
| Svennilson Peter | Director |
| Prakash Raman | Director, Executive |
| Emma Reeve | Director |
| Victoria M. Richon | Director, Executive |
| Jonathan Root | Director |
| Edward Stewart | Executive |
| Gary Sutton | Executive |
| Cameron Wheeler | Director |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
35 Cambridgepark Drive
Cambridge, MA, 02140
Cambridge, MA, 02140